{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-061208","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2026-09-10T10:02:31+00:00","discovered_at":"2026-09-10T10:05:00.506829+00:00","generated_at":"2026-09-10T10:05:08.217814+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Axogen acquires BioCircuit for $200M cash, funds via $208.7M stock offering","bullets":["Acquires BioCircuit for $200M cash; $1M withheld for post-closing adjustments; close expected Q4 2026.","Adds NerveTape, first FDA-approved sutureless nerve repair device; spin-out of BioCircuit's electronics business before close.","Priced 4.91M shares at $42.50/share for ~$208.7M gross; underwriters have 30-day option for 736,500 more.","Deal expected accretive to revenue growth, adjusted EBITDA margin, and adjusted EPS in first year post-close.","No regulatory approvals required; financing not conditioned on deal; if deal fails, proceeds for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-061208","json":"https://secwatch.observer/filing/0001628280-26-061208.json","markdown":"https://secwatch.observer/filing/0001628280-26-061208.md","text":"https://secwatch.observer/filing/0001628280-26-061208.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000162828026061208/0001628280-26-061208-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000162828026061208/axgn-20260909.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-10T10:05:08.217814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}